Literature DB >> 18755726

Ischaemia-modified albumin: clinical utility and pitfalls in measurement.

P O Collinson1, D C Gaze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18755726     DOI： 10.1136/jcp.2007.053363

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  10 in total

Review 1.  Diagnostic Accuracy of Ischemia-Modified Albumin for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Hyungoo Shin; Jae-Guk Kim; Bo-Hyoung Jang; Tae-Ho Lim; Wonhee Kim; Youngsuk Cho; Kyu-Sun Choi; Min-Kyun Na; Chiwon Ahn; Juncheol Lee
Journal:  Medicina (Kaunas)       Date:  2022-04-28       Impact factor: 2.948

2.  A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin.

Authors:  Kubilay Ukinc; Selcuk Eminagaoglu; Halil Onder Ersoz; Cihangir Erem; Caner Karahan; Arif Bayram Hacihasanoglu; Mustafa Kocak
Journal:  Endocrine       Date:  2009-09-26       Impact factor: 3.633

3.  Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome.

Authors:  Prema Gurumurthy; Sai Krishna Borra; Rama Krishna Reddy Yeruva; Dolice Victor; Sai Babu; K M Cherian
Journal:  Indian J Clin Biochem       Date:  2013-08-10

4.  Ischemia-modified albumin levels in children with chronic liver disease.

Authors:  Murat Cakir; Suleyman Caner Karahan; Ahmet Mentese; Elif Sag; Umit Cobanoglu; Tugcin Bora Polat; Erol Erduran
Journal:  Gut Liver       Date:  2012-01-12       Impact factor: 4.519

5.  Ischemia-modified albumin use as a prognostic factor in coronary bypass surgery.

Authors:  Muhip Kanko; Sadan Yavuz; Can Duman; Tulay Hosten; Emin Oner; Turan Berki
Journal:  J Cardiothorac Surg       Date:  2012-01-05       Impact factor: 1.637

Review 6.  Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.

Authors:  Ilaria Marrocco; Fabio Altieri; Ilaria Peluso
Journal:  Oxid Med Cell Longev       Date:  2017-06-18       Impact factor: 6.543

7.  Serum calprotectin and ischemia modified albumin levels as markers of disease activity in Behçet's disease.

Authors:  Ahmet Omma; Sevinc Can Sandikci; Seda Colak; Duygu Tecer; Cigdem Yucel; Zeynep Ozbalkan
Journal:  Postepy Dermatol Alergol       Date:  2018-11-13       Impact factor: 1.837

8.  Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers.

Authors:  Paul Collinson
Journal:  EJIFCC       Date:  2015-08-24

Review 9.  Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding.

Authors:  James P C Coverdale; Kondwani G H Katundu; Amélie I S Sobczak; Swati Arya; Claudia A Blindauer; Alan J Stewart
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-07-20       Impact factor: 4.006

Review 10.  Ischemia-Modified Albumin: Origins and Clinical Implications.

Authors:  Alla Shevtsova; Iuliia Gordiienko; Viktoriia Tkachenko; Galyna Ushakova
Journal:  Dis Markers       Date:  2021-07-19       Impact factor: 3.434
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.